Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

381 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cross-Modality Imaging of Murine Tumor Vasculature-a Feasibility Study.
Zopf LM, Heimel P, Geyer SH, Kavirayani A, Reier S, Fröhlich V, Stiglbauer-Tscholakoff A, Chen Z, Nics L, Zinnanti J, Drexler W, Mitterhauser M, Helbich T, Weninger WJ, Slezak P, Obenauf A, Bühler K, Walter A. Zopf LM, et al. Among authors: helbich t. Mol Imaging Biol. 2021 Dec;23(6):874-893. doi: 10.1007/s11307-021-01615-y. Epub 2021 Jun 8. Mol Imaging Biol. 2021. PMID: 34101107 Free PMC article.
Improved differentiation of benign and malignant breast tumors with multiparametric 18fluorodeoxyglucose positron emission tomography magnetic resonance imaging: a feasibility study.
Pinker K, Bogner W, Baltzer P, Karanikas G, Magometschnigg H, Brader P, Gruber S, Bickel H, Dubsky P, Bago-Horvath Z, Bartsch R, Weber M, Trattnig S, Helbich TH. Pinker K, et al. Clin Cancer Res. 2014 Jul 1;20(13):3540-9. doi: 10.1158/1078-0432.CCR-13-2810. Clin Cancer Res. 2014. PMID: 24963052
Multiparametric [18F]Fluorodeoxyglucose/ [18F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study.
Pinker K, Andrzejewski P, Baltzer P, Polanec SH, Sturdza A, Georg D, Helbich TH, Karanikas G, Grimm C, Polterauer S, Poetter R, Wadsak W, Mitterhauser M, Georg P. Pinker K, et al. PLoS One. 2016 May 11;11(5):e0155333. doi: 10.1371/journal.pone.0155333. eCollection 2016. PLoS One. 2016. PMID: 27167829 Free PMC article.
Multiparametric [11C]Acetate positron emission tomography-magnetic resonance imaging in the assessment and staging of prostate cancer.
Polanec SH, Andrzejewski P, Baltzer PAT, Helbich TH, Stiglbauer A, Georg D, Karanikas G, Susani M, Wadsak W, Margreiter M, Mitterhauser M, Brader P, Pinker K. Polanec SH, et al. Among authors: helbich th. PLoS One. 2017 Jul 18;12(7):e0180790. doi: 10.1371/journal.pone.0180790. eCollection 2017. PLoS One. 2017. PMID: 28719629 Free PMC article.
PSMA Ligand PET/MRI for Primary Prostate Cancer: Staging Performance and Clinical Impact.
Grubmüller B, Baltzer P, Hartenbach S, D'Andrea D, Helbich TH, Haug AR, Goldner GM, Wadsak W, Pfaff S, Mitterhauser M, Balber T, Berroteran-Infante N, Grahovac M, Babich J, Seitz C, Kramer G, Susani M, Mazal P, Kenner L, Shariat SF, Hacker M, Hartenbach M. Grubmüller B, et al. Among authors: helbich th. Clin Cancer Res. 2018 Dec 15;24(24):6300-6307. doi: 10.1158/1078-0432.CCR-18-0768. Epub 2018 Aug 23. Clin Cancer Res. 2018. PMID: 30139879
381 results